During the past decade, Saint Joseph Mercy Health System conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Health System" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Mayo Clinic" with 1 trials sponsored, "Michigan State University" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Health System" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Health System" are "Breast Cancer" (2 trials), "Acute Stroke" (1 trials), "Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Saint Joseph Mercy Health System" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Health System" are "Drug" (6 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Health System" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Health System". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Saint Joseph Mercy Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Health System, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".